Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The hCG diet and testosterone therapy can cause hair loss in some people.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Spironolactone is effective and safe for treating acne in women, especially those over 25 with hormonal imbalances.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Apigenin may effectively promote hair growth for androgenetic alopecia when applied topically.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Metformin lowers prolactin in men with normal hair but not in those with early hair loss.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Oral lichen planus is not linked to sex hormone levels.

Sleep, testosterone levels, and a specific enzyme activity affect skin oil production in women.

Honokiol might help reduce male skin aging by maintaining testosterone levels.